Effects of cryopreservation of pronuclear-stage rabbit zygotes on the morphological survival, blastocyst formation, and full-term development after DNA microinjection.
The objectives of this study were to examine the freezing sensitivity of pronuclear-stage rabbit zygotes and to produce transgenic rabbits using the cryopreserved zygotes. Zygotes were cryopreserved either by one of two vitrification protocols or by one of the two conventional freezing protocols. The morphological survival rates of zygotes subjected to two-step freezing in 1.5 M ethylene glycol and 0.1 M sucrose (74%) or to vitrification in 7.2 M ethylene glycol and 1.0 M sucrose (81%) were higher than those subjected to freezing in 1.5 M DMSO (46%) or to vitrification in a mixture of 2.0 M DMSO, 1.0 M acetamide, and 3.0 M propylene glycol (41%). But the in vitro development into blastocysts of zygotes cryopreserved by vitrification (17%) or to a lesser extent by freezing (52%) was impaired, when compared to that of fresh control zygotes (89%). Next, a fusion gene composed from bovine aS1-casein promoter and a human GH structural gene (2.8 kb) was microinjected into the pronucleus of rabbit zygotes frozen-thawed in ethylene glycol and sucrose. Then, the presence of exogenous DNA in the genome of newborn offspring was determined by PCR. The post-injection survival of frozen zygotes (97%) was the same as that of fresh control zygotes (96%). However, of 18 offspring derived from 414 frozen-thawed and DNA-injected zygotes, no transgenic rabbits were produced. Of 52 offspring derived from 403 DNA-injected fresh zygotes, 3 transgenic rabbits were found. Here we report the first rabbit offspring resulting from zygotes cryopreserved at the pronuclear-stage, although the cryopreservation procedure employed must be improved if zygotes are to be used for systematic production of transgenic rabbits.
Hochi
S
S
Department of Applied Biology, Faculty of Textile Science and Technology, Shinshu University, Ueda, Nagano, Japan. shochi@giptc.shinshu-u.ac.jp
Hirabayashi
M
M
Hirao
M
M
Kato
M
M
Kobayashi
T
T
Kimura
K
K
Hirasawa
K
K
Leibo
S P
SP
Ueda
M
M
D000818:Animals; D030801:Animals, Genetically Modified; D000831:Animals, Newborn; D001755:Blastocyst / Q000502:physiology*; D002417:Cattle; D015925:Cryopreservation / Q000379:methods*; D004247:DNA / Q000008:administration & dosage*; D005314:Embryonic and Fetal Development; D005260:Female; D005796:Genes; D006801:Humans; D008297:Male; D008845:Microinjections; D011401:Promoter Regions, Genetic / Q000235:genetics; D011817:Rabbits / Q000196:embryology / Q000235:genetics*; D015996:Survival Rate; D015053:Zygote / Q000254:growth & development* / Q000502:physiology; D017388:Zygote Intrafallopian Transfer / Q000379:methods*
D004247:DNA